2 1 Shi Ji Jing Ji Bao Dao·2025-03-27 13:08Core Viewpoint - Xinhua Life Insurance Company reported significant growth in its 2024 annual report, achieving record highs in multiple financial metrics, including revenue, net profit, and total assets [1][2]. Financial Performance - Total revenue for 2024 reached 132.56 billion yuan, marking an 85.3% year-on-year increase [1]. - The net profit attributable to shareholders was 26.23 billion yuan, a remarkable increase of 201.1% compared to the previous year [1][7]. - Total assets grew to 1.69 trillion yuan, reflecting a 20.6% increase year-on-year [1]. Insurance Premiums - Original insurance premium income reached 170.51 billion yuan, up 2.8% year-on-year, setting a historical high [2]. - First-year premium income for long-term insurance was 27.22 billion yuan, increasing by 15.6% [2]. - Renewal premiums accounted for 75% of total premiums, with a 5.5% year-on-year growth [2]. Shareholder Returns - Xinhua Life Insurance initiated mid-term dividends for the first time, distributing a cash dividend of 0.54 yuan per share, totaling 1.685 billion yuan [1]. - The company plans to distribute a year-end cash dividend of 1.99 yuan per share, amounting to 6.208 billion yuan, leading to a total proposed dividend of 7.893 billion yuan, a 197.6% increase from the previous year [1]. Business Structure and Strategy - The company emphasized its commitment to life insurance and enhancing product competitiveness while optimizing health and wellness service ecosystems [4]. - Xinhua Life aims to leverage opportunities in health, retirement, and wealth management, focusing on regional development, talent growth, and channel specialization [4]. Sales Channels - Individual insurance channels generated 115.97 billion yuan in premium income, a slight increase of 0.3% [5]. - The company plans to implement the "XIN Generation" project to transform its sales team and enhance productivity [5]. Investment Performance - Investment income for 2024 was 16.31 billion yuan, a turnaround from a loss of 3.775 billion yuan in 2023 [9]. - The total investment scale reached 1.629 trillion yuan, with an overall investment return rate of 5.8% [8]. - The company increased its high-dividend equity investments significantly, growing from 5.37 billion yuan to 30.64 billion yuan, a 470.6% increase [9]. Market Engagement - Xinhua Life actively participated in the equity market, acquiring stakes in companies like Shanghai Pharmaceuticals and China National Pharmaceutical Group [9]. - The company co-established a 50 billion yuan private equity fund to invest in quality listed companies, supporting long-term capital market stability [10].